News Center
Contact us
中文
About Us
Who we are
Our history
Brand culture
Our Businesses
Pharma
Medical
Diagnostics
Vaccines
Sustainability
EHS Responsibility
Education Projects
Charitable Donations
Community Services
Join us
People Strategy
Our People
Job Opportunities
News Center
Luye Pharma’s Innovative Anti-Cancer Therapy Lurbinectedin to Benefit “Named Patients” ...
2023-01-09
MORE>
Boan Biotech’s First Investigational ADC, BA1301 for Injection, Approved for Clinical Tri...
2023-01-09
MORE>
Boan Biotech Officially Listed on the Main Board of SEHK Accelerating to Become a Leading ...
2023-01-03
MORE>
Luye Pharma’s Innovative Formulation LY03010 Meets Endpoints in Pivotal U.S. Study
2022-11-22
MORE>
China’s First Denosumab Biosimilar Boyoubei® Approved for Launch by NMPA
2022-11-11
MORE>
Luye Pharma’s Class 1 Innovative Antidepressant Ruoxinlin® Approved for Launch in China
2022-11-03
MORE>
Total:
142
/ Page:
24
First
Prev
7
8
9
10
11
Next
Last
鲁ICP备05023892号-5
LUYE All Rights Reserved
Privacy policy
Terms of use
中文
TOP
TOP